{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T03:29:17Z","timestamp":1770521357547,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T00:00:00Z","timestamp":1611964800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Hemolytic Uremic Syndrome (HUS) is a rare disorder characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute renal failure, considered within the group of thrombocytic microangiopathies. Ocular complications in HUS are very rare. Here, we report an adult patient who suffered from acute onset of paracentral scotoma, caused by branch retinal artery occlusion (BRAO), as a leading symptom of atypical HUS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 39-year-old healthy male was lately diagnosed with essential hypertension and mild renal impairment. He complained about acute onset of central scotoma in his left eye. Fundus examination revealed marked narrowing of retinal vessels, cotton wool spots and few retinal hemorrhages in both eyes. The patient was diagnosed with bilateral ischemic retinal vasculopathy and acute macular BRAO in his left eye. Workup revealed thrombocytopenia, worsening renal failure. Renal biopsy showed signs of chronic thrombotic microangiopathy. The patient was diagnosed with atypical HUS (aHUS) and started on plasmapheresis, together with eculizumab. As his condition continued to worsen, he was put on renal replacement therapy. Due to a persistent monoclone of IgG1, the patient underwent bone marrow biopsy which revealed Monoclonal Gammopathy of renal significance, triggering a HUS and treatment was initiated accordingly. Two months after initial presentation, the patient developed neovascularization of the optic disc (NVD) in his left eye, and was treated with 3 monthly intravitreal bevacizumab injections with complete regression of the NVD. The patient suffered from myocardial infarction in the later course and was lost for follow-up. He returned 11\u2009months after the last bevacizumab injection because of sudden loss of vision in his left eye caused by a dense vitreous hemorrhage. Biomicroscopy revealed a new NVD in his right eye. The patient underwent panretinal photocoagulation in both eyes with regression of neovascularization. Vision improved and remained 20\/20 in both eyes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We present a case report showing retinal ischemia can be linked with aHUS. As clinal diagnosis might be challenging, physicians should be aware of the rare ocular manifestations of this devastating multi-organ disease. In case of retinal ischemia, panretinal photocoagulation should be initiated soon to avoid blinding complications.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12886-021-01820-x","type":"journal-article","created":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T11:02:53Z","timestamp":1612004573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Occlusive retinal vasculopathy with macular branch retinal artery occlusion as a leading sign of atypical hemolytic uremic syndrome \u2013 a case report"],"prefix":"10.1186","volume":"21","author":[{"given":"David P\u00e9rez","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-9108","authenticated-orcid":false,"given":"Matias","family":"Iglicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuli","family":"Svetitsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaeli","family":"Bar-On","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Habot-Wilner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinah","family":"Zur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,30]]},"reference":[{"key":"1820_CR1","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.semnephrol.2013.08.003","volume":"33","author":"D Kavanagh","year":"2013","unstructured":"Kavanagh D, Goodship TH, Richards A. Atypical hemolytic uremic syndrome. Semin Nephrol. 2013;33:508\u201330.","journal-title":"Semin Nephrol"},{"key":"1820_CR2","first-page":"1073","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet (London, England). 2005;365:1073\u201386.","journal-title":"Lancet (London, England)"},{"issue":"November 2017","key":"1820_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jim.2018.07.006","volume":"461","author":"M Sridharan","year":"2018","unstructured":"Sridharan M, Go RS, Willrich MAV. Atypical hemolytic uremic syndrome : Review of clinical presentation , diagnosis and management. J Immunol Methods. 2018;461(November 2017):15\u201322. https:\/\/doi.org\/10.1016\/j.jim.2018.07.006.","journal-title":"J Immunol Methods"},{"key":"1820_CR4","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ajo.2014.06.001","volume":"158","author":"N Jain","year":"2014","unstructured":"Jain N, Johnson MW. Pathogenesis and treatment of maculopathy associated with cavitary optic disc anomalies. Am J Ophthalmol. 2014;158:423\u201335. https:\/\/doi.org\/10.1016\/j.ajo.2014.06.001.","journal-title":"Am J Ophthalmol"},{"key":"1820_CR5","doi-asserted-by":"publisher","unstructured":"Loirat C. F-BV Atypical hemolytic uremic syndrome Orphanet J Rare Dis. 2011;6:60. https:\/\/doi.org\/10.1186\/1750-1172-6-60.","DOI":"10.1186\/1750-1172-6-60"},{"key":"1820_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1365-2141.2009.07916.x","volume":"148","author":"CM Taylor","year":"2010","unstructured":"Taylor CM, MacHin S, Wigmore SJ, Goodship THJ. Clinical practice guidelines for the management of atypical Haemolytic Uraemic syndrome in the United Kingdom. Br J Haematol. 2010;148:37\u201347.","journal-title":"Br J Haematol"},{"key":"1820_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s00467-018-4039-7","volume":"34","author":"C Formeck","year":"2019","unstructured":"Formeck C, Swiatecka-Urban A. Extra-renal manifestations of atypical hemolytic uremic syndrome. Pediatr Nephrol. 2019;34:1337\u201348.","journal-title":"Pediatr Nephrol"},{"key":"1820_CR8","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1111\/j.1755-3768.2009.01552.x","volume":"88","author":"V Sturm","year":"2010","unstructured":"Sturm V, Menke MN, Landau K, Laube GF, Neuhaus TJ. Ocular involvement in paediatric haemolytic uraemic syndrome. Acta Ophthalmol. 2010;88:804\u20137.","journal-title":"Acta Ophthalmol"},{"key":"1820_CR9","doi-asserted-by":"publisher","unstructured":"Santamar\u00eda \u00c1lvarez JF, Serret Camps A, Aguayo Alvarez J, Garc\u00eda Garc\u00eda O. Optic coherence tomography angiography follow-up in a case of Purtscher-like retinopathy due to atypical hemolytic uremic syndrome. Eur J Ophthalmol. 2020;30(3):NP14\u20137. https:\/\/doi.org\/10.1177\/1120672119833277. Epub 2019 Mar 6. PMID: 30841747.","DOI":"10.1177\/1120672119833277"},{"key":"1820_CR10","doi-asserted-by":"publisher","first-page":"348","DOI":"10.4274\/tjo.66502","volume":"47","author":"M Ustao\u011flu","year":"2017","unstructured":"Ustao\u011flu M, \u00d6nder F, Solmaz N, \u00d6zt\u00fcrk S, Ayer M. Purtscher-like retinopathy associated with atypical hemolytic uremic syndrome. Turkish J Ophthalmol. 2017;47:348\u201350.","journal-title":"Turkish J Ophthalmol"},{"key":"1820_CR11","first-page":"399","volume":"38","author":"JE Ramos de Carvalho","year":"2018","unstructured":"Ramos de Carvalho JE, Schlingemann RO, Oranje M, Bemelman FJ, van Schooneveld MJ. Reversal of threatening blindness after initiation of eculizumab in Purtscher-like retinopathy secondary to atypical hemolytic uremic syndrome. Int Ophthalmol. 2018;38:399\u2013407.","journal-title":"Int Ophthalmol"},{"key":"1820_CR12","doi-asserted-by":"publisher","first-page":"e17232","DOI":"10.1097\/MD.0000000000017232","volume":"98","author":"I-H Lin","year":"2019","unstructured":"Lin I-H, Chen Y-J, Chang P-Y, Hsiao P-W, Weng T-H, Chang Y-H. Bilateral proliferative retinopathy and ischemic optic neuropathy in a patient with atypical hemolytic-uremic syndrome: A case report. Medicine (Baltimore). 2019;98:e17232.","journal-title":"Medicine (Baltimore)"},{"key":"1820_CR13","doi-asserted-by":"publisher","unstructured":"Polito MS, Machetta F, Fea AM, Eandi CM. Hypertensive choroidopathy in atypical hemolytic-uremic syndrome. Eur J Ophthalmol. 2019. https:\/\/doi.org\/10.1177\/1120672119896286. Epub ahead of print. PMID: 31875682.","DOI":"10.1177\/1120672119896286"},{"key":"1820_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/200223b0","volume":"200","author":"GM Bernier","year":"1963","unstructured":"Bernier GM, Putnam FW. Monomer--dimer forms of bence jones proteins. Nature. 1963;200:223\u20135.","journal-title":"Nature."},{"key":"1820_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1182\/blood-2005-10-007252","volume":"108","author":"J Caprioli","year":"2006","unstructured":"Caprioli J, Noris M, Brioschi S, Pianetti G, Castelletti F, Bettinaglio P, et al. Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome. Blood. 2006;108:1267\u201379.","journal-title":"Blood."},{"key":"1820_CR16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/eye.2013.111","volume":"27","author":"R David","year":"2013","unstructured":"David R, Hochberg-Klein S, Amer R. Resolution of ocular involvement with systemic eculizumab therapy in atypical hemolytic-uremic syndrome. Eye. 2013;27:997\u20138.","journal-title":"Eye."},{"key":"1820_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s12882-019-1314-1","volume":"20","author":"J Menne","year":"2019","unstructured":"Menne J, Delmas Y, Fakhouri F, Licht C, Lommele A, Minetti EE, et al. Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study. BMC Nephrol. 2019;20:125.","journal-title":"BMC Nephrol"},{"issue":"Suppl 1","key":"1820_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1111\/nep.12934","volume":"22","author":"U Mahmood","year":"2017","unstructured":"Mahmood U, Isbel N, Mollee P, Mallett A, Govindarajulu S, Francis R. Monoclonal gammopathy of renal significance triggering atypical haemolytic uraemic syndrome. Nephrology (Carlton). 2017;22(Suppl 1):15\u20137.","journal-title":"Nephrology (Carlton)"},{"key":"1820_CR19","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/nrneph.2013.280","volume":"10","author":"M Noris","year":"2014","unstructured":"Noris M, Remuzzi G. Cardiovascular complications in atypical haemolytic uraemic syndrome. Nat Rev Nephrol. 2014;10:174\u201380.","journal-title":"Nat Rev Nephrol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-021-01820-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-021-01820-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,30]],"date-time":"2021-01-30T11:02:56Z","timestamp":1612004576000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-021-01820-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,30]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1820"],"URL":"https:\/\/doi.org\/10.1186\/s12886-021-01820-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,30]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There was no need for ethics approval or consent to participate for this case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient gave his written consent for publication of this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"65"}}